Glicia-60 MR Tablets provide an established, clinically unified oral hypoglycemic therapy carefully developed for the continuous management, long-term stabilization, and metabolic optimization of patients navigating Type 2 Diabetes Mellitus (T2DM). In progressive metabolic decline, peripheral insulin resistance paired with sluggish pancreatic response curves leads to chronic, unregulated elevations in circulating blood glucose. This sustained hyperglycemic state progressively damages capillary walls, microvascular networks, and filtering systems across the kidneys, retinas, and peripheral nerves. This advanced formulation introduces a highly reliable second-generation sulfonylurea within a standardized 60 mg modified-release matrix to re-establish normal, balanced carbohydrate metabolism safely over an ongoing chronic care routine.
The active component, Gliclazide (60 mg), functions dynamically via highly targeted pancreatic and systemic tracks:
-
Selective ATP-Sensitive Potassium Channel Blockade: Gliclazide operates directly on pancreatic beta-cell membranes by binding specifically to sulfonylurea receptors ($SUR1$). This action locks shut ATP-sensitive potassium ($K_\text{ATP}$) channels, preventing potassium ions from exiting the cell and prompting local membrane depolarization.
-
Biphasic Insulin Secretion & Extrapancreatic Sensitization: Depolarization forces the opening of voltage-dependent calcium channels, provoking a controlled intracellular calcium influx that triggers exocytosis of pre-stored insulin granules into the bloodstream. Modified-release engineering ensures that insulin discharge tracks natural meal-induced patterns around the clock. Additionally, it increases peripheral tissue sensitivity to insulin, clearing hepatic glucose overproduction and lowering microvascular thrombotic tracking profiles.
Key Benefits
-
Controlled 24-Hour Glycemic Defense: Advanced modified-release matrix delivers a flat, uniform plasma plateau, securing steady, round-the-clock blood sugar control with a single dose.
-
Low Hypoglycemia Risk Profile: Clinically recognized for its gentle, physiological insulin release curves, causing fewer sudden blood sugar drops compared to older sulfonylureas.
-
Vascular Protection Mechanism: Exhibits distinct antioxidant and anti-aggregatory features that help reduce early microvascular damage within retinal and renal fields.
-
Optimized Macro-Pack Presentation: Structured in a high-utility 10 x 10 configuration, offering an excellent anchor for chronic multi-month therapeutic compliance tracking.
-
Trusted Quality Engineering: Manufactured under strict pharmaceutical protocols of DH, ensuring exceptional active micro-dosage uniformity and steady compound release dynamics.
Directions for Use
-
Take exactly as directed by your endocrinologist, diabetologist, or primary care specialist.
-
Glicia-60 MR is strictly administered orally as a single dose once daily, taken precisely during or immediately following your morning breakfast with a full glass of plain water.
-
Mandatory Breakfast Synchronization Rule: Taking this tablet with your very first main meal of the day is absolutely mandatory. Skipping breakfast after taking this medication can cause your blood sugar to fall below safe thresholds.
-
Swallow the tablet whole. Do not crush, split, break, or chew it, as fracturing the modified-release matrix will trigger immediate drug dumping, destroying the 24-hour delivery mechanism and raising hypoglycemia risks.
Safety & Precautions
-
CRITICAL HYPOGLYCEMIA ALERT (LOW BLOOD SUGAR): This medication can cause your blood sugar to drop below safe limits if your meal timing is irregular or if you undergo uncompensated, strenuous physical exertion. Always carry fast-acting glucose sources (like sugar packets, candy, or fruit juice) to quickly counteract early symptoms of low blood sugar (sudden cold sweats, intense shaking, blurred vision, dizziness, palpitations, or confusion).
-
Do not alter your daily schedule or stop usage suddenly without professional medical auditing, as your blood glucose metrics can spike rapidly behind dangerous boundaries.
-
Avoid concurrent heavy consumption of alcohol while utilizing this medicine, as alcohol severely multiplies the tracking risk of severe, unpredictable hypoglycemic attacks.
-
Inform your specialist before initialization if you track a prior clinical record of severe liver impairment, advanced kidney filtration decline, glucose-6-phosphate dehydrogenase (G6PD) deficiency, or a known allergy to other sulfonylureas or sulfonamides.
-
Monitor your fasting blood sugar, post-prandial profiles, and HbA1c metrics regularly throughout long-term care routines.
-
Keep out of reach of children.
Storage
-
Store in a cool, dry place below 30°C.
-
Protect from direct sunlight exposure, intense radiator heat channels, and environmental room moisture pools.
-
Always keep the white tablets safely sealed inside their original protective blister strip packaging layout until the exact second of consumption to shield the core components from ambient moisture degradation.
